Solinacin Succinate Tablets is a western medicine preparation with the effect of inhibiting the overactivity of the forced urinary muscle, which can be used for the treatment of urinary incontinence, urinary urgency, urinary frequency and other symptoms caused by overactive bladder syndrome. Solinasin Succinate Tablet is a competitive muscarinic receptor antagonist drug, which can effectively inhibit the overactivity of the forced urinary muscle by blocking the muscarinic receptor of the bladder smooth muscle, and help patients with overactive bladder disease to improve the symptoms of urinary urgency, frequency, and incontinence caused by the treatment of the disease. ADVERSE REACTIONS: Some of the more common adverse reactions associated with the use of this drug include dry mouth, blurred vision, constipation, nausea, dyspepsia, and abdominal pain. CONTRAINDICATIONS: Solifenacin succinate tablets are contraindicated in myasthenia gravis, severe gastrointestinal disorders, urinary retention, and narrow-angle glaucoma. It is also contraindicated in those who are allergic to any of the components of the drug, those with severe liver dysfunction, and those undergoing hemodialysis. Precautions: If the patient has a urinary tract infection, antibacterial treatment with targeted drugs should be carried out under the supervision of a physician. The safety and efficacy of the drug in children have not been established yet, so children are not allowed to use Solynasin Succinate Tablets. The application of Solynasin Succinate Tablets needs to be strictly followed by the doctor’s instructions and should not be abused by individuals to avoid serious adverse consequences.